These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10909627)

  • 1. [The approach to patients susceptible to malignant hyperthermia].
    Ben Abraham R; Glauber V; Cahaba A; Perel A
    Harefuah; 1998 May; 134(9):736-9. PubMed ID: 10909627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia--a clinical review.
    Haddad FS
    Middle East J Anaesthesiol; 1986 Oct; 8(6):469-85. PubMed ID: 3537672
    [No Abstract]   [Full Text] [Related]  

  • 4. The genetic basis of malignant hyperthermia.
    Greenbaum I; Weigl Y; Pras E
    Isr Med Assoc J; 2007 Jan; 9(1):39-41. PubMed ID: 17274355
    [No Abstract]   [Full Text] [Related]  

  • 5. Uneventful anaesthesia does not exclude malignant hyperthermia.
    Girard T; Urwyler A
    Acta Anaesthesiol Scand; 2008 Aug; 52(7):1027-8; author reply 1028. PubMed ID: 18702756
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant hyperthermia. Physiologic and genetic principles].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1993 Jan; 16(1):18-9. PubMed ID: 8433672
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetics and susceptibility to malignant hyperthermia.
    Anderson-Pompa K; Foster A; Parker L; Wilks L; Cheek DJ; Mill TD; Dore M; McSherry G
    Crit Care Nurse; 2008 Dec; 28(6):32-6; quiz 37. PubMed ID: 19047693
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant hyperthermia need not be lethal.
    Noble E
    Can Nurse; 1980 Sep; 76(8):33-7. PubMed ID: 6901630
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant hyperthermia: an OR emergency!
    Plast Surg Nurs; 2000; 20(4):222-6. PubMed ID: 12025057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia and the otolaryngologist.
    Chang CY; Scher RL
    Ear Nose Throat J; 2003 Jun; 82(6):433-6. PubMed ID: 12861868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male preponderance of patients testing positive for malignant hyperthermia susceptibility.
    Islander G; Rydenfelt K; Ranklev E; Bodelsson M
    Acta Anaesthesiol Scand; 2007 May; 51(5):614-20. PubMed ID: 17430325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continued puzzles in malignant hyperthermia.
    Antognini JF; Gronert GA
    J Clin Anesth; 1997 Feb; 9(1):1-3. PubMed ID: 9051537
    [No Abstract]   [Full Text] [Related]  

  • 14. How carefully can we phenotype patients suspected of malignant hyperthermia susceptibility?
    Larach MG; MacLennan DH
    Anesthesiology; 1999 Mar; 90(3):645-8. PubMed ID: 10078661
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.
    Galli L; Orrico A; Lorenzini S; Censini S; Falciani M; Covacci A; Tegazzin V; Sorrentino V
    Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant hyperthermia--update 2002].
    Fiege M; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jul; 38(7):478-82. PubMed ID: 12822121
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant hyperthermia in India.
    Gupta PK; Hopkins PM
    Anaesthesia; 2010 Nov; 65(11):1063-5. PubMed ID: 20946388
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for a spontaneous C1840-T mutation in the RYR1 gene after DNA fingerprinting in a malignant hyperthermia susceptible family.
    Steinfath M; Seranski P; Singh S; Fiege M; Wappler F; Schulte Am Esch J; Scholz J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):372-5. PubMed ID: 12237752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces?
    Mathews KD; Moore SA
    Arch Neurol; 2004 Jan; 61(1):27-9. PubMed ID: 14732615
    [No Abstract]   [Full Text] [Related]  

  • 20. Genotype-phenotype comparison of the Swiss malignant hyperthermia population.
    Girard T; Urwyler A; Censier K; Mueller CR; Zorzato F; Treves S
    Hum Mutat; 2001 Oct; 18(4):357-8. PubMed ID: 11668625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.